Innovation1 Biotech Inc. (IVBT)
OTCMKTS
· Delayed Price · Currency is USD
0.0050
0.00 (0.00%)
May 9, 2025, 4:00 PM EDT
Innovation1 Biotech Income Statement
Financials in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '24 Feb 29, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | Aug '19 Aug 31, 2019 | 2017 - 2018 |
| Revenue | - | - | - | 0 | 0 | 0.08 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | 160.80% | -98.51% | 372.52% | Upgrade
|
| Cost of Revenue | - | - | 0.02 | 0.02 | 0.49 | 0.13 | Upgrade
|
| Gross Profit | - | - | -0.02 | -0.02 | -0.49 | -0.05 | Upgrade
|
| Selling, General & Admin | 0.61 | 1.17 | 2.5 | 0.24 | 0.22 | 0.62 | Upgrade
|
| Research & Development | - | 0.02 | 0.2 | - | - | - | Upgrade
|
| Operating Expenses | 0.69 | 1.27 | 5.25 | 0.24 | 0.22 | 0.62 | Upgrade
|
| Operating Income | -0.69 | -1.27 | -5.27 | -0.26 | -0.7 | -0.67 | Upgrade
|
| Interest Expense | -0.45 | -0.25 | -0.01 | -0.22 | -2.16 | -0.02 | Upgrade
|
| Interest & Investment Income | - | - | 0.01 | 0.06 | 0.04 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -1.06 | -1.06 | - | 1.45 | 0.34 | 0.52 | Upgrade
|
| EBT Excluding Unusual Items | -2.2 | -2.58 | -5.26 | 1.03 | -2.48 | -0.17 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | 0.01 | 0 | - | Upgrade
|
| Asset Writedown | -3.48 | -3.48 | -35.76 | - | -0 | -0 | Upgrade
|
| Other Unusual Items | 0.38 | 0.07 | 0.14 | - | -0.1 | - | Upgrade
|
| Pretax Income | -5.3 | -5.99 | -40.88 | 1.04 | -2.58 | -0.17 | Upgrade
|
| Net Income | -5.3 | -5.99 | -40.88 | 1.04 | -2.58 | -0.17 | Upgrade
|
| Preferred Dividends & Other Adjustments | 0.91 | 8.09 | 0.7 | - | 0.05 | 0.05 | Upgrade
|
| Net Income to Common | -6.21 | -14.08 | -41.58 | 1.04 | -2.63 | -0.22 | Upgrade
|
| Shares Outstanding (Basic) | 21 | 20 | 15 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 21 | 20 | 15 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | 11.48% | 32.57% | 7994.77% | -37.37% | -31.12% | 7.31% | Upgrade
|
| EPS (Basic) | -0.30 | -0.70 | -2.73 | 5.53 | -8.76 | -0.51 | Upgrade
|
| EPS (Diluted) | -0.30 | -0.70 | -2.73 | 5.53 | -8.76 | -0.51 | Upgrade
|
| Free Cash Flow | -0.52 | -0.62 | -3.98 | -0.03 | -0.41 | -0.78 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.03 | -0.26 | -0.16 | -1.37 | -1.79 | Upgrade
|
| Gross Margin | - | - | - | - | - | -63.21% | Upgrade
|
| Operating Margin | - | - | - | -8390.94% | -59486.79% | -841.52% | Upgrade
|
| Profit Margin | - | - | - | 33764.03% | -222723.79% | -278.08% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -987.18% | -34737.34% | -987.42% | Upgrade
|
| EBITDA | -0.69 | -1.27 | -2.86 | -0.26 | -0.7 | -0.66 | Upgrade
|
| D&A For EBITDA | 0 | 0 | 2.41 | 0 | 0 | 0 | Upgrade
|
| EBIT | -0.69 | -1.27 | -5.27 | -0.26 | -0.7 | -0.67 | Upgrade
|
| Advertising Expenses | - | 0.01 | 0 | 0 | 0 | 0.09 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.